Home » Vaccine » Page 9

Vaccine

US health chief sceptical of Russia’s coronavirus vaccine claim

United States health chief on Wednesday expressed scepticism about Russia’s claim of developing the world’s first safe coronavirus vaccine, pointing to the lack of data from its initial trials. The post US health chief sceptical of Russia’s coronavirus vaccine claim appeared first on TODAY. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.

Two coronavirus vaccines proven safe for human – research

Two coronavirus vaccine have proven safe for humans and produced strong immune reactions among patients involved in separate clinical trials, doctors said Monday. The first trial among more than 1,000 adults in Britain found that the vaccine-induced “strong antibody and T cell immune responses” against the novel coronavirus. A separate trial in China involving more than 500 people showed most had developed widespread antibody immune response. The studies, published in The Lancet medical journal, constitute a major step on the road towards a COVID-19 vaccine that is effective and safe for widespread use. The authors of the studies said that they encountered a few adverse side effects from the vaccine candidates. However, they cautioned that more research was needed, particularly among older...

South Africa Begins First COVID-19 Vaccine Trial

Sourced from Getty Images The University of Witswatersrand has announced that South Africa’s first COVID-19 vaccine trial is set to begin, with participants to be enrolled by the end of the week. “This is a landmark moment for South Africa and Africa at this stage of the COVID-19 pandemic. As we enter winter in South Africa and pressure increases on public hospitals, now more than ever we need a vaccine to prevent infection by COVID-19,” Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Shabir Madhi, says in a virtual briefing. This new trial aims to find a vaccine that will prevent SARS-CoV-2 infection, which is the virus that causes COVID-19. “We began screening participants for ...

House of Reps urges speedy production of local coronavirus vaccines in Nigeria

The House of Representatives has stressed the need for speedy production of local vaccines for the treatment of COVID-19 in Nigeria. The House also mandated its standing Committees on Healthcare Services, Health Institutions and Aids, Tuberculosis and Malaria to invite the Hon. Minister, Federal Ministry of Health, the Executive Director/CEO, National Primary Health Care Development Agency, the Director General, Nigeria Centre for Disease Control and the Executive Director, May and Baker Nigeria PLC to brief the Committees and deliberate on possible ways of getting the needed legislative support to fast track the production of vaccines in Nigeria and report back within four (4) weeks for further legislative action The resolutioms followed the adoption of a motion on notice, moved by Rep. J...

US coronavirus death toll exceeds 90,000 as Donald Trump urges reopening

The coronavirus death toll in the United States surpassed 90,000 on Monday as the total number of confirmed COVID-19 cases exceeded 1.5 million across the country, according to the Johns Hopkins University tally. The grim milestones came as President Donald Trump tweeted to “REOPEN OUR COUNTRY!” and the White House attempted to shift blame, including onto its own scientists, for the high number of deaths. On Sunday, members of Trump administration disagreed on whether the US Centers for Disease Control and Prevention (CDC) let the country down with testing efforts. “Early on in this crisis, the CDC, which really had the most trusted brand around the world in this space, really let the country down with the testing,” Peter Navarro, Trump’s trade adviser, told NBC’s Meet the Press programme....

HIV-Fighting Strategy Could Help Against COVID-19

Sourced from Getty Images. While vaccines for the world-stopping coronavirus could be months, or even years away – there are some researchers who are looking to see if they can stop people who are at high risk of getting sick in the first place. The Verge writes that this is a proven strategy and preventative drugs have been used for decades to help people protect themselves against malaria, and more recently, against HIV. There has never been an effective vaccine against HIV, but now people can take a daily medication that reduces the risks of contracting the disease from sexual activity by 99%. Known as Pre-Exposure Prophylactic, or PrEP, the drug is used to prevent disease in people who haven’t yet been exposed to it. “We have an incredibly powerful tool that can, for myself personally,...

SGF: Nigeria did not request for Madagascar herbal medicine

The Nigerian government has said it did not request for COVID-Organics, a herbal medicine used by Madagascar to treat COVID-19 patients. The Secretary to the Government of the Federation (SGF), Boss Mustapha, made this known at the daily Presidential Task Force on COVID-19 briefing on Thursday. Mr Mustapha said the medicine was offered as a general gesture of ‘brotherly love’ from the Malagasy government to all African countries. “Nigeria did not ask Madagascar for any solution, the Madagascar government decided to airlift quantities meant for African countries. ”It was taken in the spirit of African brotherly love to Guinea Bissau and we have asked our ambassador there to establish the location, the quantity and he has done that,” he said. Mr Mustapha, at a past briefing, had noted that t...

Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine

Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...

  • 1
  • 8
  • 9